-
'New drug policy to negatively impact investment in pharmas'
"At a company level, we were aware of the upcoming policy and have factored in the impact which is likely to be in the range of 3-4 per cent of our finished dosage sales in India. We have plans in place to ride over this impact," Dr Reddy's Laboratories Vice-Chairman and MD Satish Reddy said. #Pharmaceuticals in India #WhoSaidWhat #Dr. Reddy's Laboratories #drug policy
-
Sun Pharma ends deal to take over Taro
The companies decided that ending the deal was in the best interest of their shareholders, Sun Pharma and Taro said in a joint filing. #DealStream #Sun Pharma #Taro Pharmaceutical Industries
-
Prosecution likely in Rs 700 crore case, time for Asaram Bapu to say his mantras?
The godman's trust has been accused of grabbing property worth Rs 700 crore that belongs to a pharmaceutical company. #NewsTracker #Serious Fraud Investigation Office #Land-Grab #Asaram Bapu #Pharmaceutical company
-
Indias cancer burden: Why the govts CL ruling is so important
The Indian government's steps to issue compulsory license for three more cancer drugs - Trastuzumab, Dasatinib and Ixabepilone - is welcome. Here's why. #HowThisWorks #India #Cancer #Pharmaceutical industry #patents #Compulsory Licensing
-
IT services, pharma likely to be biggest employers in 2013
Information Technology services and pharmaceuticals are likely to drive hiring growth in 2013, to fill mid and senior positions, said HeadHonchos.com, a leading job search and career management portal. #Pharmaceuticals in India #jobs #Employment #Information technology #2013 #FastForward2013
-
India's poor: Pharma industry's favourite 'guinea pigs'?
India's poor, willingly and unwillingly, have turned out to be the favourite guinea pigs for pharma companies in India and abroad. #HowThisWorks #Pharmaceutical industry #human drug trials
-
New drug price policy will hurt pharma sector's profits: Industry bodies
Prices of various leading drug brands will come down thanks to the newly-approved National Pharmaceutical Pricing Policy but at the same time it will hurt investment sentiments in the country's pharmaceutical sector, according to industry bodies. #NewsTracker #Drugs #National Pharmaceutical Pricing Policy #Medicines in India
-
New drug policy cleared, essential drugs to cost less
The government cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices. #NewsTracker #National Pharmaceutical Pricing Policy #Medicine prices in India
-
Lupin Q2 net up 9% to Rs 291 crore
Drug firm Lupin today said its consolidated net profit rose by 8.84 percent to Rs 290.5 crore for the second quarter ended September 30, 2012, on the back of robust sales across the US, India and Japan markets. #EarningsShow #pharmaceuticals #Lupin #Q2 Results
-
Dr Reddy's to buy Netherland's OctoPlus NV for Rs 193 cr
Dr Reddy's Laboratories has decided to acquire Netherlands-based OctoPlus NV, a speciality pharmaceutical company, for about 27.4 million euros #DealStream #Dr. Reddy's Laboratories #OctoPlus NV #pharmaceutical